Cargando...
Biomarkers for evaluation of clinical efficacy of multipotential neuroprotective drugs for Alzheimer’s and Parkinson’s diseases
During the last century, the world population has shown a staggering increase in its proportion of elderly members and thus neurodegenerative diseases like Alzheimer’s disease (AD) and Parkinson’s disease (PD), respectively, are becoming an increasing burden on society. Among the diverse, significan...
Gardado en:
Publicado en: | Neurotherapeutics |
---|---|
Main Authors: | , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado: |
Springer-Verlag
2009
|
Assuntos: | |
Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5084261/ https://ncbi.nlm.nih.gov/pubmed/19110204 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nurt.2008.10.033 |
Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|